423 related articles for article (PubMed ID: 23360884)
21. The crosstalk between gut microbiota and obesity and related metabolic disorders.
Xu WT; Nie YZ; Yang Z; Lu NH
Future Microbiol; 2016 Jun; 11():825-36. PubMed ID: 27192213
[TBL] [Abstract][Full Text] [Related]
22. The role of the gut microbiota in energy metabolism and metabolic disease.
Cani PD; Delzenne NM
Curr Pharm Des; 2009; 15(13):1546-58. PubMed ID: 19442172
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiome and metabolic diseases.
Fukuda S; Ohno H
Semin Immunopathol; 2014 Jan; 36(1):103-14. PubMed ID: 24196453
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties.
Druart C; Alligier M; Salazar N; Neyrinck AM; Delzenne NM
Adv Nutr; 2014 Sep; 5(5):624S-633S. PubMed ID: 25225347
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
Esteve E; Ricart W; Fernández-Real JM
Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
[TBL] [Abstract][Full Text] [Related]
26. Impact of the gut microbiota, prebiotics, and probiotics on human health and disease.
Lin CS; Chang CJ; Lu CC; Martel J; Ojcius DM; Ko YF; Young JD; Lai HC
Biomed J; 2014; 37(5):259-68. PubMed ID: 25179725
[TBL] [Abstract][Full Text] [Related]
27. The role of the gut microbiota in metabolic health.
Janssen AW; Kersten S
FASEB J; 2015 Aug; 29(8):3111-23. PubMed ID: 25921831
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota in older subjects: variation, health consequences and dietary intervention prospects.
O'Connor EM; O'Herlihy EA; O'Toole PW
Proc Nutr Soc; 2014 Nov; 73(4):441-51. PubMed ID: 24824449
[TBL] [Abstract][Full Text] [Related]
29. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.
Caesar R; Fåk F; Bäckhed F
J Intern Med; 2010 Oct; 268(4):320-8. PubMed ID: 21050286
[TBL] [Abstract][Full Text] [Related]
30. Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents.
Ejtahed HS; Soroush AR; Angoorani P; Larijani B; Hasani-Ranjbar S
Horm Metab Res; 2016 Jun; 48(6):349-58. PubMed ID: 27203411
[TBL] [Abstract][Full Text] [Related]
31. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.
Neyrinck AM; Possemiers S; Verstraete W; De Backer F; Cani PD; Delzenne NM
J Nutr Biochem; 2012 Jan; 23(1):51-9. PubMed ID: 21411304
[TBL] [Abstract][Full Text] [Related]
32. Carbohydrates and the human gut microbiota.
Chassard C; Lacroix C
Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):453-60. PubMed ID: 23719143
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders.
Musso G; Gambino R; Cassader M
Curr Opin Lipidol; 2010 Feb; 21(1):76-83. PubMed ID: 19915460
[TBL] [Abstract][Full Text] [Related]
34. Targeting gut microbiota in obesity: effects of prebiotics and probiotics.
Delzenne NM; Neyrinck AM; Bäckhed F; Cani PD
Nat Rev Endocrinol; 2011 Aug; 7(11):639-46. PubMed ID: 21826100
[TBL] [Abstract][Full Text] [Related]
35. Diabetes, obesity and gut microbiota.
Everard A; Cani PD
Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):73-83. PubMed ID: 23768554
[TBL] [Abstract][Full Text] [Related]
36. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota.
Cani PD; Delzenne NM
Curr Opin Pharmacol; 2009 Dec; 9(6):737-43. PubMed ID: 19628432
[TBL] [Abstract][Full Text] [Related]
37. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats.
Parnell JA; Reimer RA
Br J Nutr; 2012 Feb; 107(4):601-13. PubMed ID: 21767445
[TBL] [Abstract][Full Text] [Related]
38. Immune system and gut flora interactions are important episodes in metabolic diseases.
Jain S; Marotta F; Catanzaro R; Yadav H
J Gastrointestin Liver Dis; 2012 Dec; 21(4):347-8. PubMed ID: 23256115
[No Abstract] [Full Text] [Related]
39. The gut microbial metabolome: modulation of cancer risk in obese individuals.
Russell WR; Duncan SH; Flint HJ
Proc Nutr Soc; 2013 Feb; 72(1):178-88. PubMed ID: 23174203
[TBL] [Abstract][Full Text] [Related]
40. Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?
Brahe LK; Astrup A; Larsen LH
Adv Nutr; 2016 Jan; 7(1):90-101. PubMed ID: 26773017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
